Cooper Companies (COO) vs STAAR Surgical (STAA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
STAAR Surgical (STAA) has outperformed Cooper Companies (COO) over the past year, losing 16.3% versus a loss of 20.7%. Over five years, COO leads with a -45.0% price change compared with -80.5% for STAA. Cooper Companies is the larger company by market cap ($10.41 billion vs $1.12 billion), about 9.3 times the size.
On valuation, Cooper Companies trades at a lower forward P/E (11.7x vs 20.1x for STAAR Surgical).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COO | STAA |
|---|---|---|
| Share price | $54.75 | $22.36 |
| Market cap | $10.41B | $1.12B |
| 1-day change | -2.98% | +0.95% |
| YTD return | -33.20% | -3.16% |
| 1-year return | -20.68% | -16.32% |
| 5-year return | -45.02% | -80.54% |
| P/E ratio (TTM) | 19.41 | 279.50 |
| Forward P/E | 11.67 | 20.12 |
| EPS (TTM) | $2.82 | $0.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.09B | — |
| Revenue growth (YoY) | +5.06% | — |
| Net income (latest FY) | $374.90M | — |
| Gross margin | 65.54% | — |
| Operating margin | 16.69% | — |
| Net margin | 9.16% | — |
| 52-week high | $89.83 | $35.87 |
| 52-week low | $51.01 | $15.59 |
| Distance from 52-week high | -39.05% | -37.66% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +20.18% | +25.22% |
| Average volume | 3.11M | 1.00M |
| Shares outstanding | 190.16M | 50.14M |
| Employees | 15,000 | 921 |
| Sector | Health Care | Healthcare |
| Industry | Ophthalmic Goods | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cooper Companies is about 9.3 times larger than STAAR Surgical by market value ($10.41B vs $1.12B).
- STAAR Surgical trades at a higher earnings multiple (279.5x vs 19.4x trailing P/E).
- The two companies sit in different sectors: Cooper Companies in Health Care and STAAR Surgical in Healthcare.
About Cooper Companies
COO stock →The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Health Care · Ophthalmic Goods · 15,000 employees
About STAAR Surgical
STAA stock →STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Healthcare · Medical Instruments & Supplies · 921 employees
COO vs STAA FAQ
Which is bigger, Cooper Companies or STAAR Surgical?
Cooper Companies (COO) is larger, with a market capitalization of $10.41B compared with $1.12B for STAAR Surgical (STAA).
Which stock has performed better over the past year, COO or STAA?
STAA returned -16.32% over the past 12 months, compared with -20.68% for COO (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, COO or STAA?
COO has the lower trailing P/E at 19.4, versus 279.5 for STAA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cooper Companies and STAAR Surgical in the same industry?
No. Cooper Companies is in the Health Care sector, while STAAR Surgical is in Healthcare.